| polymorphism | factor | odds ratio | pvalue | initial number | replication number | Population | age of cases | shorter lived allele | longer lived allele | study type | reference |
| rs11136000 | CLU | — | 0.975 | 1364 | — | American, British | Age range 50-108; mean age at death 80.2 | A | G | Candidate Region/Gene | 22445811 |
| rs744373 | BIN1 | — | 0.689 | 1364 | — | American, British | Age range 50-108; mean age at death 80.2 | A | G | Candidate Region/Gene | 22445811 |
| rs1485780 | CD2AP | — | 0.604 | 1364 | — | American, British | Age range 50-108; mean age at death 80.2 | C | A | Candidate Region/Gene | 22445811 |
| rs3818361 | CR1 | — | 0.563 | 1364 | — | American, British | Age range 50-108; mean age at death 80.2 | G | A | Candidate Region/Gene | 22445811 |
| rs2275075 | LMNA | — | 0.54 | 873 vs 443 | New England Centenarian Study: 545 vs 193; French: 557 vs 546; Southern Italian Centenarian Study: 455 vs 450; Ashkenazi Jewish: 354 vs 348 | American, Caucasian | Mean age 101.5 | — | — | Candidate Region/Gene | 22340368 |
| rs3865444 | CD33 | — | 0.442 | 1364 | — | American, British | Age range 50-108; mean age at death 80.2 | C | A | Candidate Region/Gene | 22445811 |
| rs11767557 | EPHA1 | — | 0.267 | 1364 | — | American, British | Age range 50-108; mean age at death 80.2 | G | A | Candidate Region/Gene | 22445811 |
| rs3851179 | PICALM | — | 0.227 | 1364 | — | American, British | Age range 50-108; mean age at death 80.2 | G | A | Candidate Region/Gene | 22445811 |
| rs610932 | MS4A6A | — | 0.176 | 1364 | — | American, British | Age range 50-108; mean age at death 80.2 | C | A | Candidate Region/Gene | 22445811 |
| rs3764650 | ABCA7 | — | 0.135 | 1364 | — | American, British | Age range 50-108; mean age at death 80.2 | C | A | Candidate Region/Gene | 22445811 |
| HRAS1 LASS1 (CCT) | APOE | — | 0.0511 | 68 vs 68 | — | American | — | — | — | Candidate Region/Gene | 20569235 |
| −438 G/A | TAFI | 0.53 | 0.003 | 2224 | — | American, Caucasian | 65+ | G (men) | — | Candidate Region/Gene | 15939070 |
| HRAS1 LASS1 (CCT) | APOE | — | 0.00197 | 125 vs 163 | — | American | — | — | — | Candidate Region/Gene | 20569235 |
| rs6459623 | IBRDC2 | — | 0.00015 | 1345 cohort + 1087 offspring | — | American | — | — | — | Genome-Wide Association Study | 17903295 |
| rs1405051 | — | — | 0.00014 | 1345 cohort + 1087 offspring | — | American | — | — | — | Genome-Wide Association Study | 17903295 |
| rs1915501 | — | — | 0.00011 | 1345 cohort + 1087 offspring | — | American | — | — | — | Genome-Wide Association Study | 17903295 |
| HRAS1 LASS1 (CCT) | APOE | — | 9.5e-05 | 204 vs 251 | — | American | — | — | — | Candidate Region/Gene | 20569235 |
| rs10498263 | OR4Q3 | — | 8.3e-05 | 1345 cohort + 1087 offspring | — | American | — | — | — | Genome-Wide Association Study | 17903295 |
| rs3757354 | MYLIP | — | 6.4e-05 | 1345 cohort + 1087 offspring | — | American | — | — | — | Genome-Wide Association Study | 17903295 |
| rs6657082 | — | — | 5.5e-05 | 1345 cohort + 1087 offspring | — | American | — | — | — | Genome-Wide Association Study | 17903295 |
| rs10493517 | — | — | 4.2e-05 | 1345 cohort + 1087 offspring | — | American | — | — | — | Genome-Wide Association Study | 17903295 |
| rs10489006 | — | — | 3.6e-05 | 1345 cohort + 1087 offspring | — | American | — | — | — | Genome-Wide Association Study | 17903295 |
| rs10493518 | — | — | 3.6e-05 | 1345 cohort + 1087 offspring | — | American | — | — | — | Genome-Wide Association Study | 17903295 |
| rs10493515 | — | — | 2.3e-05 | 1345 cohort + 1087 offspring | — | American | — | — | — | Genome-Wide Association Study | 17903295 |
| rs6689491 | — | — | 2e-05 | 1345 cohort + 1087 offspring | — | American | — | — | — | Genome-Wide Association Study | 17903295 |
